C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions

Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
12/2011
12/22/2011	WO2011160042A2 Prpk-tprkb modulators and uses thereof
12/22/2011	WO2011160016A2 E3 binding pockets and identification and use of e3 ligase inhibitors
12/22/2011	WO2011159942A1 Conformational probes and methods for sequencing nucleic acids
12/22/2011	WO2011159924A2 Compositions and methods for identifying and modifying carbonaceous compositions
12/22/2011	WO2011159797A2 A compendium of ready-built stem cell models for interrogation of biological response
12/22/2011	WO2011159721A2 System and method for magnetically concentrating and detecting biomarkers
12/22/2011	WO2011159713A2 Compositions and methods for gene expression and chromatin profiling of individual cell types within a tissue
12/22/2011	WO2011159658A2 Methods,assays, and kits related to dichloroacetate (dca)
12/22/2011	WO2011159629A2 Salt selection of microbial mutants to increase bioproduct tolerance, titer, or osmotic shock tolerance
12/22/2011	WO2011159256A1 Modified stem-loop oligonucleotide mediated reverse transcription and base-spacing constrained quantitative pcr
12/22/2011	WO2011159054A2 Method for identifying proper storage of goods requiring storage at low temperature
12/22/2011	WO2011159004A1 Snp for predicting the sensitivity to anticancer targeted therapeutic formulation
12/22/2011	WO2011158987A1 Dna chip for genotyping of human papilloma virus, kit having same, and method for genotyping
12/22/2011	WO2011158847A1 Kit for detection of gene targeted by microrna, and method for detection of gene targeted by microrna
12/22/2011	WO2011158815A1 Method for simultaneous achievement of bacteriolysis of acid-fast bacterium and separation of nucleic acid from the bacterium
12/22/2011	WO2011158784A1 Method for large-scale parallel nucleic acid analysis
12/22/2011	WO2011158736A1 Method for high-speed and high-sensitivity molecule detection/quantification via charge measurement using power generation enzyme, and detection part and device to be used for the method
12/22/2011	WO2011158667A1 Method for detection of colorectal tumor
12/22/2011	WO2011158655A1 Use with utilization of soluble klotho-, fgf23- and fgfr-complex formation mechanism in calcified tissue
12/22/2011	WO2011158243A2 Method of diagnosing and treating cancer
12/22/2011	WO2011158191A1 Monitoring of immune system using peripheral blood micro-rna expression profile analysis and uses thereof
12/22/2011	WO2011158061A1 Mlk4 gene, a new diagnostic and prognostic marker in cancers
12/22/2011	WO2011158037A2 Methods and apparatuses
12/22/2011	WO2011157982A1 Fluorescent -labelled diubiquitin substrate for a deubiquitinase assay
12/22/2011	WO2011157976A1 Control of plant seed shattering
12/22/2011	WO2011157846A1 Methods for haplotyping single cells
12/22/2011	WO2011157828A1 Biomarkers for determination of temporal phase of acute kidney injury
12/22/2011	WO2011157683A1 Extraction of nucleic acids from wax-embedded samples
12/22/2011	WO2011157678A1 Method for determination of target cells or tissue for extraction of biomolecules from fixed biological samples
12/22/2011	WO2011157617A1 Complex set of mirna libraries
12/22/2011	WO2011157283A1 Treatment of coagulopathy with hyperfibrinolysis
12/22/2011	WO2011157222A1 Joint detection methods for lymphoma fusion genes and diagnostic kits thereof
12/22/2011	WO2011156970A1 Uses of mtea in diagnosis and treatment of malignant tumor
12/22/2011	WO2011156885A1 Use of psychrophilic anaerobic digestion in sequencing batch reactor for degradation of prions
12/22/2011	WO2011156857A1 Microfluidic device with dialysis section having stomata tapering counter to flow direction
12/22/2011	WO2011156852A1 Genetic analysis loc with non-specific nucleic acid amplification section and subsequent specific amplification of particular sequences in a separate section
12/22/2011	WO2011156851A1 Test module with diffusive mixing in small cross section area microchannel
12/22/2011	WO2011156850A1 Microfluidic device with pcr section and diffusion mixer
12/22/2011	WO2011156849A1 Test module with microfluidic device having loc and dialysis device for separating pathogens from other constituents in a biological sample
12/22/2011	WO2011156847A1 Microfluidic device for genetic and mitochondrial analysis of a biological sample
12/22/2011	WO2011156846A1 Microfluidic device for simultaneous detection of multiple conditions in a patient
12/22/2011	WO2011156845A1 Loc device with parallel incubation and parallel dna and rna amplification functionality
12/22/2011	WO2011156844A1 Loc device for genetic analysis which performs nucleic acid amplification before removing non-nucleic acid constituents in a dialysis section
12/22/2011	WO2011156843A1 Loc device for genetic analysis which performs nucleic acid amplification after sample preparation in a dialysis section
12/22/2011	WO2011156842A1 Loc device for pathogen detection and genetic analysis with dialysis and nucleic acid amplification
12/22/2011	WO2011156841A1 Loc device for pathogen detection with dialysis, thermal lysis, nucleic acid amplification and prehybridization filtering
12/22/2011	WO2011156840A1 Loc device for pathogen detection and genetic analysis with chemical lysis, incubation and tandem nucleic acid amplification
12/22/2011	WO2011156839A1 Loc device for genetic analysis with dialysis, chemical lysis and tandem nucleic acid amplification
12/22/2011	WO2011156838A1 Loc device for pathogen detection with dialysis, chemical lysis and tandem nucleic acid amplification
12/22/2011	WO2011156837A1 Loc device for pathogen detection with dialysis, thermal lysis, nucleic acid amplification and prehybridization filtering
12/22/2011	WO2011137911A3 Method for generating a double stranded nucleic acid with a single stranded overhang
12/22/2011	WO2011137288A3 Mirna networks in cancers and leukemias and uses thereof
12/22/2011	WO2011130184A3 SYSTEMS AND METHODS FOR MODEL-BASED qPCR
12/22/2011	WO2011116402A3 Surface enhanced raman spectroscopy
12/22/2011	WO2011110955A3 Methods of testing for intracellular pathogens
12/22/2011	WO2011100057A3 Methods and compositions for universal detection of nucleic acids
12/22/2011	WO2011097663A3 Method for genotyping blood samples for red blood cell and/or platelet surface antigens
12/22/2011	WO2011097561A3 Methods and systems for fluid examination and remediation
12/22/2011	WO2011097327A3 Compositions and methods of modulating receptor protein tyrosine phosphatases
12/22/2011	WO2011094535A3 Biomarkers of aging for detection and treatment of disorders
12/22/2011	WO2011094483A3 Immune gene signatures in cancer
12/22/2011	WO2011091324A3 Methods of generating zinc finger nucleases having altered activity
12/22/2011	WO2011088026A3 Biomarkers of liver injury
12/22/2011	WO2011081421A3 Complement c9 as markers for the diagnosis of cancer
12/22/2011	WO2011079017A9 Differentiation of human embryonic stem cells
12/22/2011	WO2011066458A3 Novel genomic biomarkers for irritable bowel syndrome diagnosis
12/22/2011	WO2010111891A8 Modified oligo-nucleic acid molecule, preparation method and uses thereof
12/22/2011	US20110313672 Cellular antioxidant activity (caa) assay
12/22/2011	US20110313276 Non-invasive in vitro method for quantifying liver lesions
12/22/2011	US20110313233 Down-regulation of cold shock proteins for cancer treatment
12/22/2011	US20110313029 Diagnostic and therapeutic uses of gnptab, gnptg, and nagpa in stuttering
12/22/2011	US20110313027 Methods and substances for stimulating muscle regeneration
12/22/2011	US20110313026 Dna and proteins or peptides specific of bacteria of the neisseria meningitidis species, methods for obtaining them and biological applications thereof
12/22/2011	US20110313022 Compositions and Methods for Diminishing Viral Infection and Inflammation Associated with Viral Infection
12/22/2011	US20110313018 Cancer related gene, lgn/gpsm2
12/22/2011	US20110312981 Predictive marker for egfr inhibitor treatment
12/22/2011	US20110312968 Method for optimizing the treatment of chronic myeloid leukemia with abl tyrosine kinase inhibitors
12/22/2011	US20110312918 Method for identifying agents for inhibiting cell motility and invasiveness
12/22/2011	US20110312907 Polymorphisms predictive of anthracycline- induced cardiotoxicity
12/22/2011	US20110312897 Cathepsin l proteolytically processes histone h3 during mouse embryonic stem cell differentiation
12/22/2011	US20110312894 Methods of diagnosing and treating neurodegenerative diseases
12/22/2011	US20110312876 Method of determining types I, II, III, IV or V or methicillin-resistant staphylococcus aureus (MRSA) in a biological sample
12/22/2011	US20110312543 Expression Vectors Based on Modified Ribosomal Protein Promoters and Uses Thereof in Post-Transcriptional Assessment
12/22/2011	US20110312534 Method for prediction of human iris color
12/22/2011	US20110312533 CELL LINES EXPRESSING NaV AND METHODS OF USING THEM
12/22/2011	US20110312532 Gene Expression Markers for Breast Cancer Prognosis
12/22/2011	US20110312531 Clinically intelligent diagnostic devices and methods
12/22/2011	US20110312530 Gene expression signature for classification of tissue of origin of tumor samples
12/22/2011	US20110312524 Methods employing non-coding rna expression assays
12/22/2011	US20110312520 Methods and compositions for diagnosing conditions
12/22/2011	US20110312519 Genetic factors associated with inhibitor development in hemophilia a
12/22/2011	US20110312516 Diagnostic and prognostic use of human bladder cancer-associated micro rnas
12/22/2011	US20110312515 Identification of markers in lung and breast cancer
12/22/2011	US20110312514 Method For Determination And Quantification Of Radiation Or Genotoxin Exposure
12/22/2011	US20110312513 Biomarkers for predicting sustained response to hcv treatment
12/22/2011	US20110312512 Culture system and method for immunogenicity and immunofunction testing in vitro
12/22/2011	US20110312509 Biomarkers downregulated in prostate cancer
12/22/2011	US20110312507 Reaction discovery system
12/22/2011	US20110312505 Rapid Isolation of Monoclonal Antibodies from Animals
12/22/2011	US20110312504 Methods, kits, and compositions for detection of mrsa

1 ... 528 529 530 531 532 533 534 535 536 537 538 539 540 541 542 543 544 545 546 547 548 ... 3003